Latest Breaking News On - Quantitative motor assessments - Page 1 : comparemela.com

Alterity Therapeutics Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology

Alterity Therapeutics Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesDavid stamlerRemy bernardaHannah howlettDaniel claassenAlterity therapeuticsEuropean commissionAmerican academy of neurology annual meetingVanderbilt university medical centerMultiple system atrophyAmerican academyNeurology annualWearable sensorsQuantitative motor assessmentsPrincipal investigator

Alterity Therapeutics (ATHE) Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology

Alterity Therapeutics (ATHE) Presents Promising Wearable Sensor Data from the bioMUSE Natural History Study at the American Academy of Neurology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel claassenDavid stamlerAmerican academy of neurology annual meetingEuropean commissionVanderbilt university medical centerSystem atrophy national institute of neurological disordersWall streetMultiple system atrophyAmerican academyNeurology annualWearable sensorsQuantitative motor assessmentsPrincipal investigatorChief executive officerAssociate professor

Appendix 4C - Q1 FY23 Quarterly Cash Flow Report

First patient dosed in Phase 2 clinical trial for ATH434 in New Zealand, trial opens in Europe and AustraliaApproval of Investigational New Drug a.

United statesNew zealandUnited kingdomSan franciscoDavid stamlerNational institute of healthAmerican neurological association annual meetingSystem atrophy coalitionHealth biotechItalian medicines agencyAlterity therapeuticsMovement disordersCompany phaseCompany american depositary shares adssPrnewswire alterity therapeutics limitedDrug administration

Alterity Therapeutics announces poster presentation from major study

Alterity Therapeutics announces poster presentation from major study
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Daniel claassenDavid stamlerMovement disordersInternational congressAlterity therapeuticsMultiple system atrophyWearable sensorsQuantitative motor assessmentsAssociate professorVanderbilt university medical centerPrincipal investigator

Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson s Disease and Movement Disorders

/PRNewswire/ Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying.

United statesSan franciscoDaniel claassenDavid stamlerMovement disordersVanderbilt university medical centerNational institute of healthEuropean commissionInternational congressAlterity therapeuticsValidates useWearable sensorsOngoing phaseMultiple system atrophyQuantitative motor assessmentsAssociate professor